The UK is investing heavily in preparation for mass manufacturing of a working COVID-19 vaccine.
Articles on Pharmaceutical industry
Displaying 41 - 60 of 68 articles
Toilet paper shortages were bad enough. A shortage of drugs during the COVID-19 pandemic would be worse. A provision in the Canadian government’s relief package aims to prevent that from happening.
Drug shortages occur regularly in the US, even in the best of times. The pharmaceutical supply chain embodies ‘just in time’ shipping and has little built-in redundancy.
Too often, pharmaceutical companies and device manufacturers exert influence in how their products are tested in the research phase and recommended in the clinic.
The government should work with drug companies, not against them.
The first study to assess the carbon footprint of the pharmaceutical industry finds that it is far from green.
Two community pharmacists suggest a way for improving the palatability of evidence-based universal pharmacare – for those working in health insurance, pharmacy and the pharmaceutical industry.
Fixes for small pieces of massive problems show that overarching crises may be less hopeless than they appear.
These four “natural” therapies for depression have rigorous, peer-reviewed scientific studies to support their use.
Researchers who’ve created a kidney-on-a-chip explain why these kinds of devices are an improvement over traditional ways to test new drugs.
Pharmaceutical companies focus on small molecules they’ve devised – and can easily patent. But nature’s already come up with many antibacterial compounds that drug designers could use to make medicines.
Health Canada proposes to increase fees to the pharmaceutical industry for prescription drug approval. This will compromise drug safety and is a risk to the health of the Canadian public.
Rather than being designed by chemists, this class of pharmaceuticals is produced by living cells. Here’s where they come from and how they work.
Holding patents can be a lucrative and powerful position to be in. Here’s a proposal for how nonprofit patent holders can do more for the common good – and live up to their end of the tax break bargain.
Without leading edge innovations and coordination, Canadians will die from the epidemic of antibiotic resistant infections.
Drug companies funded more than 116,000 educational events for doctors over four years. Now you can find out exactly which companies footed the bills and how much they paid.
Globalised drug manufacturing is adding to the problem of antimicrobial resistance.
A push towards prescribing generic medications rather than their branded equivalents, as flagged in the budget, may have benefits beyond simple cost savings.
Australia is spending more than A$500 million a year too much for pharmaceuticals because of a little known loophole that allows drug companies to overcharge the government.
Firms with a focus on the domestic and regional market have an incentive to distribute their medicines effectively. Local production can create a win-win situation for health and employment.
Top contributors
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Professor in Pharmaceutical Policy, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Senior Research Manager, University of Sydney and Honorary Assistant Professor, Bond University
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Professor of Philosophy, Binghamton University, State University of New York
-
Professor, School of Population and Public Health, University of British Columbia
-
Associate Professor in Psychological Medicine, University of Auckland, Waipapa Taumata Rau
-
Graduate Student, University of Manitoba
-
Associate Professor & Chair of Eco-Entrepreneurship, McMaster University
-
Professor and Head, Division of Clinical Pharmacology, Faculty of Medicine and Health Sciences, Stellenbosch University
-
Professor of Health Economics, Flinders University
-
Research Assistant Professor of Pharmacy, University of Washington
-
Professor of Chemistry, Northeastern University
-
Associate Professor in Pharmacology, Flinders University
-
Honorary Research Fellow, University of Bath